Profiel
Hugh M.
Cole formerly worked at Millennium Pharmaceuticals, Inc., as Senior Director-Business Development & Strategy, Astria Therapeutics, Inc., as Independent Director from 2019 to 2026, Oscient Pharmaceuticals Corp., as Vice President-Corporate Development from 2003 to 2007, ARIAD Pharmaceuticals, Inc., as Chief Business Officer & Senior Vice President from 2014 to 2017, Shire Pharmaceuticals, Inc., as Senior VP-Strategic Planning & Program Management from 2012 to 2014, and Jounce Therapeutics, Inc., as Chief Operating Officer from 2022 to 2023.
Mr. Cole received his undergraduate degree from Harvard University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Eerdere bekende functies van Hugh Cole
| Bedrijven | Functie | Einde |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Directeur/Bestuurslid | 23-01-2026 |
| JOUNCE THERAPEUTICS, INC. | Operationeel Directeur | 15-03-2023 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-07-2017 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01-03-2014 |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Markets and sells products to community-based primary care physicians | Corporate Officer/Principal | 01-03-2007 |
Opleiding van Hugh Cole
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Markets and sells products to community-based primary care physicians | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















